Doctor's Bio
Board Certifications
American Board of Radiology
Affiliations
Emory
Education & Training
- Medical School: The Ohio State University College of Medicine
- Internship: Riverside Methodist Hospital
- Residency: The Ohio State University Wexner Medical Center
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Volumetric Changes and Acute Toxicity with Ga Prostate-Specific Membrane Antigen vs F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial.
Dhere VR, Schuster DM, Goyal S, Schreibmann E, Sebastian NT, Patel SA, Hanasoge S, Shelton JW, Patel PR, Hershatter BW, Abiodun-Ojo OA, Lawal IO, Jani AB
Practical radiation oncology. 2025;
PMID: 40738247 - Hypoxic Gene Expression Signature as a Predictor of Recurrence and Mortality in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Eustace NJ, Sebastian NT, Webb A, Shilo K, Robb R, Amini A, Yang L, Denko NC, Williams TM
JCO precision oncology. 2025;
PMID: 40466027 - Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States.
Sebastian NT, Patil D, Patel PR, Jani AB, Hershatter BW, Dhere VR, Godette KD, Lorentz CA, Weiss AD, Joshi SS, Sanda MG, Patel SA
Cancer. 2025;131(6):e35795.
PMID: 40038572 - Diuresis During F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial.
Lawal IO, Mushtaq A, Jani AB, Rupji M, Dhere VR, Patel SA, Bilen MA, Patel PR, Sebastian NT, Switchenko JM, Schuster DM, Marcus C
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2025;66(2):230-237.
PMID: 39848765 - Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy.
Sebastian NT, Goyal S, Liu Y, Dhere V, Jani AB, Hershatter B, Patel PR, Shelton JW, Hanasoge S, Godette KD, Patel SA
Journal of contemporary brachytherapy. 2024;16(4):268-272.
PMID: 39628817 - The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Sebastian NT, Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z, Burns A, Sukhatme V, Lowe MC, Ramalingam SS, Sukhatme VP, Moghanaki D
The oncologist. 2025;
PMID: 39321212 - Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy.
Dhere VR, Goyal S, Zhou J, Sebastian NT, Patel AB, Hanasoge S, Patel PR, Shelton J, Godette KD, Hershatter BW, Jani AB, Patel SA
International journal of particle therapy. 2024;
PMID: 39070664 - Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial.
Dhere VR, Schuster DM, Goyal S, Schreibmann E, Hershatter BW, Patel SA, Shelton JW, Hanasoge S, Patel PR, Sebastian NT, Adediran OA, Lawal IO, Jani AB
Practical radiation oncology. 2024;14(6):e492-e499.
PMID: 39032598 - Lung Cancer Survival Trends in the Veterans Health Administration.
Moghanaki D, Taylor J, Bryant AK, Vitzthum LK, Sebastian N, Gutman D, Burns A, Huang Z, Lewis JA, Spalluto LB, Williams CD, Sullivan DR, Slatore CG, Behera M, Stokes WA
Clinical lung cancer. 2024;25(3):225-232.
PMID: 38553325 - A PI3K gene expression signature predicts for recurrence in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Sebastian NT, Webb A, Shilo K, Robb R, Xu-Welliver M, Haglund K, Brownstein J, DeNicola GM, Shen C, Williams TM
Cancer. 2023;129(24):3971-3977.
PMID: 37560930
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.